Femara 2.5 mg Film Coated Tablet
- Name:
Femara 2.5 mg Film Coated Tablet
- Company:
Novartis Ireland Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 25/02/21

Click on this link to Download PDF directly
Novartis Ireland Limited

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 25 February 2021 PIL
Reasons for updating
- Change to section 2 - excipient warnings
Updated on 25 February 2021 SPC
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 12 May 2020 PIL
Reasons for updating
- Change to section 6 - manufacturer
Updated on 27 November 2019 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
Updated on 27 November 2019 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 9 May 2019 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 22 March 2019 PIL
Reasons for updating
- Change to section 4 - how to report a side effect
Updated on 22 January 2019 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 24 July 2018 SPC
Reasons for updating
- Change to MA holder contact details
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 24 July 2018 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 3 September 2015 PIL
Reasons for updating
- New PIL for new product
Updated on 3 September 2015 PIL
Reasons for updating
- Addition of information on reporting a side effect.
Updated on 23 April 2014 PIL
Reasons for updating
- Change to warnings or special precautions for use
Updated on 21 December 2012 PIL
Reasons for updating
- Change to, or new use for medicine
- Change to warnings or special precautions for use
- Change of contraindications
- Change to how the medicine works
Updated on 14 April 2009 PIL
Reasons for updating
- Change to information about pregnancy or lactation
- Change to side-effects
Updated on 5 September 2008 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change of contraindications
Updated on 30 January 2007 PIL
Reasons for updating
- Change due to harmonisation of patient information leaflet
Updated on 29 August 2006 PIL
Reasons for updating
- Change to, or new use for medicine
Updated on 16 May 2005 PIL
Reasons for updating
- Change to, or new use for medicine
Updated on 25 August 2004 PIL
Reasons for updating
- New PIL for medicines.ie